6G3Q
Crystal structure of human carbonic anhydrase II in complex with the inhibitor famotidine
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID30B |
Synchrotron site | ESRF |
Beamline | ID30B |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2018-03-13 |
Detector | DECTRIS PILATUS3 2M |
Wavelength(s) | 0.827 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 42.316, 41.439, 72.112 |
Unit cell angles | 90.00, 104.34, 90.00 |
Refinement procedure
Resolution | 41.000 - 1.010 |
R-factor | 0.1283 |
Rwork | 0.127 |
R-free | 0.15150 |
Structure solution method | FOURIER SYNTHESIS |
Starting model (for MR) | 4fik |
RMSD bond length | 0.009 |
RMSD bond angle | 1.427 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | REFMAC |
Refinement software | REFMAC |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 41.000 | 41.000 | 1.080 |
High resolution limit [Å] | 1.010 | 2.840 | 1.010 |
Rmerge | 0.038 | 0.028 | 0.601 |
Rmeas | 0.048 | 0.036 | 0.765 |
Total number of observations | 282854 | ||
Number of reflections | 112412 | 5519 | 14931 |
<I/σ(I)> | 10.8 | 33.5 | 1.35 |
Completeness [%] | 88.6 | 93.7 | 65.1 |
Redundancy | 2.516 | 2.499 | 2.374 |
CC(1/2) | 0.998 | 0.997 | 0.639 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 8 | 296 | 1.5 M sodium citrate, Tris 50 mM |